Form 4: Albemarle Director Dean Seavers Boosts Stake Through Stock Compensation and Dividend Reinvestment
Insider Transaction Report
Albemarle Corporation Director Dean Seavers acquired 2,762 shares of common stock on July 1, 2025, through annual director compensation and dividend reinvestment, increasing his direct beneficial ownership to 12,021 shares.
Summary
- Dean Seavers, a Director of Albemarle Corporation (ALB), acquired a total of 2,762 shares of common stock on July 1, 2025.
- This includes 2,725 shares received as an annual installment of non-employee director stock compensation under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors, with these shares set to vest on July 1, 2026.
- An additional 37 shares were acquired, representing dividends accrued on a stock award granted on July 1, 2024, which vested in full on July 1, 2025, and were settled in common stock under the 2023 Directors Plan.
- Following these transactions, Dean Seavers directly beneficially owns 12,021 shares of Albemarle Corporation common stock.
Sentiment
Score: 7
Explanation: The acquisition of shares by a director, particularly through compensation and dividend reinvestment, is generally a positive signal as it increases insider ownership and aligns management interests with shareholders. It's a routine transaction but still indicates confidence in the company's future.
Positives
- Director Dean Seavers increased his direct beneficial ownership in Albemarle Corporation by 2,762 shares, further aligning his interests with shareholders.
- The acquisition of shares through stock compensation and dividend reinvestment demonstrates a commitment to the company's long-term performance and strategy.
Future Outlook
The filing indicates future vesting of 2,725 shares of common stock on July 1, 2026, as part of the non-employee director stock compensation plan.
Industry Context
This Form 4 filing reflects standard corporate governance practices where non-employee directors receive a portion of their compensation in company stock, a common practice across various industries to align director interests with shareholder value and promote long-term commitment.
Comparison to Industry Standards
- The practice of compensating non-employee directors with company stock, as seen with Albemarle Corporation, is a widely adopted corporate governance standard across publicly traded companies, including peers in the specialty chemicals and materials sector such as FMC Corporation (FMC) or Livent Corporation (LTHM) before its merger, aiming to align director incentives with long-term shareholder value.
- The use of a stock compensation and deferral plan for directors is consistent with best practices for executive and director compensation, promoting retention and long-term commitment, similar to plans observed at companies like DuPont (DD) or BASF SE (BASFY).
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorization of Power of Attorney | Dean L. Seavers granted a Power of Attorney to Ander Krupa, Rebekah Richards, Amanda Miljenovic, and Brenda Mareski to handle SEC filings (Forms 3, 4, 5, 13D, 13G, 144), manage his EDGAR account, and perform related actions. | 2025-06-02 | This streamlines the process for the director's SEC compliance filings, ensuring timely and accurate reporting of beneficial ownership changes. |
| Director Compensation Plan | The transactions are pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors, indicating a structured approach to director remuneration that includes equity. | 2025-07-01 | Reinforces alignment of director interests with long-term shareholder value through equity-based compensation. |
Stakeholder Impact
- Shareholders: Increased alignment of director interests with shareholder value due to increased insider ownership.
Next Steps
- The 2,725 shares acquired as annual director compensation are scheduled to vest on July 1, 2026.
Key Dates
| Date | Description |
|---|---|
| 2023-01-01 | Reference to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation. |
| 2024-07-01 | Date of award grant on which dividends accrued for 37 shares. |
| 2025-06-02 | Date of execution of the Power of Attorney by Dean L. Seavers. |
| 2025-07-01 | Transaction date for the acquisition of 2,725 shares of common stock as annual director compensation and 37 shares from dividend reinvestment; also the vesting date for the award granted on July 1, 2024. |
| 2025-07-03 | Signature date of the Form 4 filing by Rebekah Richards, Attorney-in-Fact. |
| 2026-07-01 | Scheduled vesting date for the 2,725 shares acquired as annual director compensation. |
Recommendation
holdKeywords
Albemarle Corporation, ALB, Form 4, SEC filing, insider transaction, director compensation, stock acquisition, beneficial ownership, dividend reinvestment, corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.